Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taiwo A Ademoye

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Analyst|February 17, 2026
Differences in α-synuclein conformational states in physiologically relevant pH/Na<sup>+</sup> concentrations and ammonium acetate solutions unveiled by native mass spectrometryErick G Báez Bolívar, Jessica S Fortin, Taiwo A Ademoye, et al.
Scientific Reports|October 30, 2025
A high-throughput drug screening assay for anti-tau aggregation using split GFP and flow cytometryOmnia M H Ibrahium, Taiwo A Ademoye, Jessica S Fortin, et al.
Biochemistry and Biophysics Reports|April 11, 2025
The aggregation tendencies of the signal peptide regions of prone and not prone to aggregate proteinsNatalie G Horgan, Anabela Djurovic-Topalovic, Taiwo A Ademoye, et al.
Bioorganic & Medicinal Chemistry|February 8, 2024
Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrilsAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
Bioorganic & Medicinal Chemistry|November 17, 2024
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tauAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|March 3, 2025
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein AggregatesAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|September 8, 2025
In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α‑Synuclein and Tau AggregationTaiwo A Ademoye, Susantha K Ganegamage, Behrad Masoudi, et al.
Biochemistry and Biophysics Reports|December 1, 2025
Epigallocatechin-3-Gallate: A potential amyloid Fibril Disaggregator of Serum amyloid A1Natalie G Horgan, Anabela Djurovic-Topalovic, Taiwo A Ademoye, et al.
ACS Chemical Neuroscience|October 22, 2024
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease TherapeuticsSusantha K Ganegamage, Taiwo A Ademoye, Henika Patel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Analyst|February 17, 2026
Differences in α-synuclein conformational states in physiologically relevant pH/Na<sup>+</sup> concentrations and ammonium acetate solutions unveiled by native mass spectrometryErick G Báez Bolívar, Jessica S Fortin, Taiwo A Ademoye, et al.
Scientific Reports|October 30, 2025
A high-throughput drug screening assay for anti-tau aggregation using split GFP and flow cytometryOmnia M H Ibrahium, Taiwo A Ademoye, Jessica S Fortin, et al.
Biochemistry and Biophysics Reports|April 11, 2025
The aggregation tendencies of the signal peptide regions of prone and not prone to aggregate proteinsNatalie G Horgan, Anabela Djurovic-Topalovic, Taiwo A Ademoye, et al.
Bioorganic & Medicinal Chemistry|February 8, 2024
Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrilsAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
Bioorganic & Medicinal Chemistry|November 17, 2024
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tauAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|March 3, 2025
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein AggregatesAhmed A Elbatrawy, Taiwo A Ademoye, Heba Alnakhala, et al.
ACS Omega|September 8, 2025
In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α‑Synuclein and Tau AggregationTaiwo A Ademoye, Susantha K Ganegamage, Behrad Masoudi, et al.
Biochemistry and Biophysics Reports|December 1, 2025
Epigallocatechin-3-Gallate: A potential amyloid Fibril Disaggregator of Serum amyloid A1Natalie G Horgan, Anabela Djurovic-Topalovic, Taiwo A Ademoye, et al.
ACS Chemical Neuroscience|October 22, 2024
Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease TherapeuticsSusantha K Ganegamage, Taiwo A Ademoye, Henika Patel, et al.
Pageof 1